We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (219)
- Scheduling (national classification system) (59)
- Manufacturing (28)
- Advertising (22)
- Unique Device Identification (UDI) hub (21)
- Safety monitoring and information (17)
- Compliance and enforcement (15)
- Clinical trials (10)
- Vaping hub (9)
- Legislation (8)
- Medicinal cannabis hub (5)
- Shortages and supply disruptions (3)
- Breast implant hub (2)
- Cosmetics (1)
- Import and export (1)
- Labelling and packaging (1)
Search
465 result(s) found, displaying 51 to 75
-
-
PresentationsPresented at the ARCS Annual Conference 2024.
-
PresentationsWebinar Wednesday 5 June
-
WebinarsAbout the inclusion of medical devices to the GCP inspection program and the recent updates to the GCP inspection program guidance document in what to expect and how to prepare for an inspection. A recording of the webinar will be available.
-
PresentationsPresented at the General Practice Conference and Exhibition (Sydney) 2024
-
PresentationsWebinar 1 Wednesday May 8. Webinar 2 Friday May 10.
-
PresentationsSee the video recording of our digital transformation program webinar. We demonstrate the first parts of the new online system, being built to make it easier to work with us.
-
PresentationsUpdate on improvements in TGA standards for quality and safety of unapproved vapes
-
PresentationsThis presentation is about our revised guidance on advertising health services which involve cosmetic injectables.
-
WebinarsWe will provide an overview of the Medicines Repurposing Program and how interested stakeholders can propose potential new therapeutic uses of existing medicines.
-
PresentationsThis presentation is an introduction to the new in-house IVD notification form and notification template.
-
WebinarsWe showcased changes to the Clinical Trials Notifications (CTN) form and explained how the review of CTNs for the highest risk medical device clinical trials will operate in practice.
-
PresentationsThis presentation describes the data requirements and the assessment approach need for in-house IVDs, including Companion Diagnostics.
-
WebinarsWe will provide an overview of the Medicines Repurposing Program and how interested stakeholders can propose potential new therapeutic uses of existing medicines.
-
Presentation: NATA TGA IVD information session 1 - Refresher: Regulatory framework for in-house IVDs
PresentationsThis presentation describes the data requirements and the assessment approach need for in-house IVDs, including Companion Diagnostics. -
-
PresentationsWatch our webinar that provides information for prescribers on the vaping reforms, in partnership with the Royal Australian College of General Practitioners (RACGP) and Quit Centre,
-
WebinarsThis webinar provides information on the TGA’s public consultation on the impacts, challenges and opportunities relating to medicine shortages.
-
Committee meetingsAdvisory Committee on Medical Devices (ACMD) meeting
-
Committee meetingsAdvisory Committee on Medicines (ACM) meeting
-
WebinarsLearn about vaping reforms and how these will impact consumers, suppliers and health professionals.
-
Committee meetingsAdvisory Committee on Medical Devices (ACMD) meeting
-
Committee meetingsAdvisory Committee on Medicines (ACM) meeting
-
-
WebinarsWe provided an update on the Australian UDI implementation and a guest speaker presented on the real-world benefits of the UDI adoption in the US healthcare system. See the slides and video.